206 related articles for article (PubMed ID: 22850622)
1. Expression of microRNAs in patients with pancreatic cancer and its prognostic significance.
Papaconstantinou IG; Manta A; Gazouli M; Lyberopoulou A; Lykoudis PM; Polymeneas G; Voros D
Pancreas; 2013 Jan; 42(1):67-71. PubMed ID: 22850622
[TBL] [Abstract][Full Text] [Related]
2. Expression of microRNA-218 in human pancreatic ductal adenocarcinoma and its correlation with tumor progression and patient survival.
Zhu Z; Xu Y; Du J; Tan J; Jiao H
J Surg Oncol; 2014 Feb; 109(2):89-94. PubMed ID: 24166773
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis.
Nakata K; Ohuchida K; Mizumoto K; Kayashima T; Ikenaga N; Sakai H; Lin C; Fujita H; Otsuka T; Aishima S; Nagai E; Oda Y; Tanaka M
Surgery; 2011 Nov; 150(5):916-22. PubMed ID: 22018284
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of microRNA-93 downregulation in human colon cancer.
Xiao ZG; Deng ZS; Zhang YD; Zhang Y; Huang ZC
Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):296-301. PubMed ID: 23354160
[TBL] [Abstract][Full Text] [Related]
5. Changes in miR-143 and miR-21 expression and clinicopathological correlations in pancreatic cancers.
Tavano F; di Mola FF; Piepoli A; Panza A; Copetti M; Burbaci FP; Latiano T; Pellegrini F; Maiello E; Andriulli A; di Sebastiano P
Pancreas; 2012 Nov; 41(8):1280-4. PubMed ID: 22836856
[TBL] [Abstract][Full Text] [Related]
6. Claudin-4 expression predicts survival in pancreatic ductal adenocarcinoma.
Tsutsumi K; Sato N; Tanabe R; Mizumoto K; Morimatsu K; Kayashima T; Fujita H; Ohuchida K; Ohtsuka T; Takahata S; Nakamura M; Tanaka M
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S491-9. PubMed ID: 21837532
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm.
Xue Y; Abou Tayoun AN; Abo KM; Pipas JM; Gordon SR; Gardner TB; Barth RJ; Suriawinata AA; Tsongalis GJ
Cancer Genet; 2013 Jun; 206(6):217-21. PubMed ID: 23933230
[TBL] [Abstract][Full Text] [Related]
8. Circulating microRNAs in serum of human K-ras oncogene transgenic rats with pancreatic ductal adenocarcinomas.
Yabushita S; Fukamachi K; Tanaka H; Sumida K; Deguchi Y; Sukata T; Kawamura S; Uwagawa S; Suzui M; Tsuda H
Pancreas; 2012 Oct; 41(7):1013-8. PubMed ID: 22513294
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-10a is overexpressed in human pancreatic cancer and involved in its invasiveness partially via suppression of the HOXA1 gene.
Ohuchida K; Mizumoto K; Lin C; Yamaguchi H; Ohtsuka T; Sato N; Toma H; Nakamura M; Nagai E; Hashizume M; Tanaka M
Ann Surg Oncol; 2012 Jul; 19(7):2394-402. PubMed ID: 22407312
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma.
Xue A; Scarlett CJ; Jackson CJ; Allen BJ; Smith RC
Pancreas; 2008 Mar; 36(2):160-7. PubMed ID: 18376307
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-203 expression as a new prognostic marker of pancreatic adenocarcinoma.
Ikenaga N; Ohuchida K; Mizumoto K; Yu J; Kayashima T; Sakai H; Fujita H; Nakata K; Tanaka M
Ann Surg Oncol; 2010 Dec; 17(12):3120-8. PubMed ID: 20652642
[TBL] [Abstract][Full Text] [Related]
12. Molecular subtypes of pancreatic cancer based on miRNA expression profiles have independent prognostic value.
Namkung J; Kwon W; Choi Y; Yi SG; Han S; Kang MJ; Kim SW; Park T; Jang JY
J Gastroenterol Hepatol; 2016 Jun; 31(6):1160-7. PubMed ID: 26644397
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of miR-194 contributes to tumor growth and progression in pancreatic ductal adenocarcinoma.
Zhang J; Zhao CY; Zhang SH; Yu DH; Chen Y; Liu QH; Shi M; Ni CR; Zhu MH
Oncol Rep; 2014 Mar; 31(3):1157-64. PubMed ID: 24398877
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance.
Hashiguchi Y; Nishida N; Mimori K; Sudo T; Tanaka F; Shibata K; Ishii H; Mochizuki H; Hase K; Doki Y; Mori M
Int J Oncol; 2012 May; 40(5):1477-82. PubMed ID: 22322911
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-183 is involved in cell proliferation, survival and poor prognosis in pancreatic ductal adenocarcinoma by regulating Bmi-1.
Zhou L; Zhang WG; Wang DS; Tao KS; Song WJ; Dou KF
Oncol Rep; 2014 Oct; 32(4):1734-40. PubMed ID: 25109303
[TBL] [Abstract][Full Text] [Related]
16. Reduced miRNA-218 expression in pancreatic cancer patients as a predictor of poor prognosis.
Li BS; Liu H; Yang WL
Genet Mol Res; 2015 Dec; 14(4):16372-8. PubMed ID: 26662432
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA expression analyses in preoperative pancreatic juice samples of pancreatic ductal adenocarcinoma.
Sadakari Y; Ohtsuka T; Ohuchida K; Tsutsumi K; Takahata S; Nakamura M; Mizumoto K; Tanaka M
JOP; 2010 Nov; 11(6):587-92. PubMed ID: 21068491
[TBL] [Abstract][Full Text] [Related]
18. MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma.
Vychytilova-Faltejskova P; Kiss I; Klusova S; Hlavsa J; Prochazka V; Kala Z; Mazanec J; Hausnerova J; Kren L; Hermanova M; Lenz J; Karasek P; Vyzula R; Slaby O
Diagn Pathol; 2015 Apr; 10():38. PubMed ID: 25908274
[TBL] [Abstract][Full Text] [Related]
19. High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1.
Qian B; Katsaros D; Lu L; Preti M; Durando A; Arisio R; Mu L; Yu H
Breast Cancer Res Treat; 2009 Sep; 117(1):131-40. PubMed ID: 18932017
[TBL] [Abstract][Full Text] [Related]
20. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.
Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]